Imaging, Digital, Angiography Symposium 1

Related

• 

  Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy

  Michael J Allingham, MD, PhD

  Annual Meeting Talks

  2022

• 

  Integrin Antagonism for DME

  Hugo Quiroz-Mercado, MD

  Updates from the Field

  2019

• 

  Switching to Combination OPT-302 With Aflibercept From Prior Anti-VEGF-A Monotherapy in Eyes With Persistent Diabetic Macula Edema (DME)

  David S. Boyer, MD

  Annual Meeting Talks

  2020